EC Healthcare Schedules Board Meeting to Review Interim Results
I'm PortAI, I can summarize articles.
EC Healthcare has announced a board meeting on 28 November 2025 to review interim results for the six months ending 30 September 2025 and discuss potential interim dividends. This meeting will provide insights into the company's financial health and potential returns for stakeholders. The latest analyst rating for EC Healthcare stock is a Hold with a HK$0.50 price target. The company operates in the healthcare industry and is listed on the Hong Kong Stock Exchange.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments